327 related articles for article (PubMed ID: 17157755)
1. Opioid use and survival at the end of life: a survey of a hospice population.
Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
[TBL] [Abstract][Full Text] [Related]
2. Increasing opioid therapy and survival in a hospice.
Azoulay D; Hammerman-Rozenberg R; Cialic R; Ein Mor E; Jacobs JM; Stessman J
J Am Geriatr Soc; 2008 Feb; 56(2):360-1. PubMed ID: 18251818
[No Abstract] [Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. High dose controlled-release oxycodone in hospice care.
Bercovitch M; Adunsky A
J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
[TBL] [Abstract][Full Text] [Related]
5. Pain, demographics, and clinical characteristics in persons who received hospice care in the United States.
Strassels SA; Blough DK; Hazlet TK; Veenstra DL; Sullivan SD
J Pain Symptom Manage; 2006 Dec; 32(6):519-31. PubMed ID: 17157754
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
7. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population.
Good PD; Ravenscroft PJ; Cavenagh J
Intern Med J; 2005 Sep; 35(9):512-7. PubMed ID: 16105151
[TBL] [Abstract][Full Text] [Related]
8. Trends in the use of opioids at the end of life and the expected effects on hastening death.
Rurup ML; Borgsteede SD; van der Heide A; van der Maas PJ; Onwuteaka-Philipsen BD
J Pain Symptom Manage; 2009 Feb; 37(2):144-55. PubMed ID: 18692359
[TBL] [Abstract][Full Text] [Related]
9. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
Bercovitch M; Adunsky A
Cancer; 2004 Sep; 101(6):1473-7. PubMed ID: 15368335
[TBL] [Abstract][Full Text] [Related]
10. A population-based evaluation of an intervention to improve advanced stage cancer pain management.
Hoffmann W; Munzinger H; Horstkotte E; Greiser E
J Pain Symptom Manage; 2004 Oct; 28(4):342-50. PubMed ID: 15471651
[TBL] [Abstract][Full Text] [Related]
11. Opioids, survival, and advanced cancer in the hospice setting.
Azoulay D; Jacobs JM; Cialic R; Mor EE; Stessman J
J Am Med Dir Assoc; 2011 Feb; 12(2):129-34. PubMed ID: 21266289
[TBL] [Abstract][Full Text] [Related]
12. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
Webster BS; Verma SK; Gatchel RJ
Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
[TBL] [Abstract][Full Text] [Related]
13. Opioid use in dying patients in hospice and hospital, with and without specialist palliative care team involvement.
Brown W
Eur J Cancer Care (Engl); 2008 Jan; 17(1):65-71. PubMed ID: 18181893
[TBL] [Abstract][Full Text] [Related]
14. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain.
Coffey RJ; Owens ML; Broste SK; Dubois MY; Ferrante FM; Schultz DM; Stearns LJ; Turner MS
Anesthesiology; 2009 Oct; 111(4):881-91. PubMed ID: 20029253
[TBL] [Abstract][Full Text] [Related]
15. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
18. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
Gallagher RM; Welz-Bosna M; Gammaitoni A
Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
[TBL] [Abstract][Full Text] [Related]
19. Clinical and demographic characteristics help explain variations in pain at the end of life.
Strassels SA; Blough DK; Veenstra DL; Hazlet TK; Sullivan SD
J Pain Symptom Manage; 2008 Jan; 35(1):10-9. PubMed ID: 17959344
[TBL] [Abstract][Full Text] [Related]
20. What is the risk of distress in palliative care survey research?
Takesaka J; Crowley R; Casarett D
J Pain Symptom Manage; 2004 Dec; 28(6):593-8. PubMed ID: 15589084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
